OPKO Health Inc (OPK)
1.32
+0.02
(+1.54%)
USD |
NASDAQ |
May 06, 16:00
1.32
0.00 (0.00%)
After-Hours: 05:13
OPKO Health Enterprise Value: 1.073B for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 1.073B |
| May 03, 2024 | 1.060B |
| May 02, 2024 | 1.060B |
| May 01, 2024 | 1.039B |
| April 30, 2024 | 1.004B |
| April 29, 2024 | 1.018B |
| April 26, 2024 | 1.032B |
| April 25, 2024 | 1.004B |
| April 24, 2024 | 1.011B |
| April 23, 2024 | 1.025B |
| April 22, 2024 | 1.011B |
| April 19, 2024 | 1.011B |
| April 18, 2024 | 1.011B |
| April 17, 2024 | 1.025B |
| April 16, 2024 | 996.81M |
| April 15, 2024 | 1.011B |
| April 12, 2024 | 1.011B |
| April 11, 2024 | 1.049B |
| April 10, 2024 | 1.039B |
| April 09, 2024 | 1.115B |
| April 08, 2024 | 1.129B |
| April 05, 2024 | 1.094B |
| April 04, 2024 | 1.101B |
| April 03, 2024 | 1.094B |
| April 02, 2024 | 1.094B |
| Date | Value |
|---|---|
| April 01, 2024 | 1.067B |
| March 28, 2024 | 989.84M |
| March 27, 2024 | 899.23M |
| March 26, 2024 | 857.41M |
| March 25, 2024 | 857.41M |
| March 22, 2024 | 825.76M |
| March 21, 2024 | 801.65M |
| March 20, 2024 | 773.77M |
| March 19, 2024 | 760.04M |
| March 18, 2024 | 756.69M |
| March 15, 2024 | 777.11M |
| March 14, 2024 | 770.56M |
| March 13, 2024 | 794.19M |
| March 12, 2024 | 800.18M |
| March 11, 2024 | 809.94M |
| March 08, 2024 | 820.82M |
| March 07, 2024 | 816.49M |
| March 06, 2024 | 807.92M |
| March 05, 2024 | 805.06M |
| March 04, 2024 | 850.44M |
| March 01, 2024 | 845.49M |
| February 29, 2024 | 850.44M |
| February 28, 2024 | 840.33M |
| February 27, 2024 | 885.29M |
| February 26, 2024 | 848.00M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
756.69M
Minimum
Mar 18 2024
4.254B
Maximum
Jul 21 2020
1.925B
Average
1.604B
Median
Sep 16 2022
Enterprise Value Benchmarks
| Innerscope Hearing Technologies Inc | -- |
| Stryker Corp | 134.46B |
| Perspective Therapeutics Inc | 1.067B |
| Xtant Medical Holdings Inc | 130.69M |
| Asensus Surgical Inc | 45.19M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -66.48M |
| Revenue (Quarterly) | 181.90M |
| Total Expenses (Quarterly) | 250.96M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 24.58% |
| Profit Margin (Quarterly) | -36.55% |
| Earnings Yield | -18.94% |
| Normalized Earnings Yield | -18.96 |